SIFI Announces the Granting of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis
/PRNewswire/ -- SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug...
United States Edward Holland Sebastiano Giuffrida Maria Grazia Mazzone Jelle Kleijn Business Portfolio Development
Source: prnewswire.com